Reaching proof of concept

Reaching proof of concept

Obesity
Company Product Description Target/ Mechanism Milestones
Alizyme Cetilistat (ATL-962) Lipase inhibitor Lipase Start Ph III 1H07 (A)
Amylin Pramlintide/leptin Synthetic amylin analog/recombinant leptin Amylin receptor/leptin receptor Ph II data 07

Read the full 367 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE